ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Significant Drop in Short Interest

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the recipient of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 400 shares, a drop of 96.0% from the January 31st total of 10,000 shares. Based on an average trading volume of 408,500 shares, the short-interest ratio is presently 0.0 days.

ProtoKinetix Stock Up 8.0 %

Shares of OTCMKTS:PKTX traded up $0.00 during trading hours on Friday, hitting $0.01. 175,629 shares of the company’s stock traded hands, compared to its average volume of 177,719. The business has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.01. ProtoKinetix has a 1 year low of $0.01 and a 1 year high of $0.02.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.